Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. FDXF
9. RKLB
10. SPCX

Go back to Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
(NASDAQ: PLSE) Delayed: 28.45 +0.94 (3.42%)
Previous Close $27.51    52 Week High $6.77 
Open $26.92    52 Week Low $4.03 
Day High $31.00    P/E N/A 
Day Low $26.85    EPS $0.00 
Volume 1,813,743